Bristol Myers Squibb settles AWP lawsuit
Bristol Myers Squibb (NYSE:BMY) is the latest defendant to reach a settlement with plaintiffs in the massive Average Wholesale Price litigation (In re Pharmaceutical Average Wholesale Price Litigation, before Judge Patti Saris of the U.S. District Court
PAL member Public Patent Foundation challenges Gilead HIV/AIDS drug patents
The Public Patent Foundation ("PubPat") is a member of the PAL Coalition. PUBPAT is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by unde
Premarin Class Action Settlement
Consumers and third party payors in California who paid for Premarin, used to relieve the symptoms associated with menopause and to prevent osteoporosis in postmenopausal women, may be eligible to receive payments from a $5.2 million settlement fund. Fo
YouTube video on Paxil Pediatric settlement
Our friends at Public Citizen recently posted this YouTube video on the Paxil Pediatric settlement, and the upcoming deadline for parents or guardians of children who took Paxil to file claims to receive refunds from this $63.8 million settlement fund. (S
Breast Cancer Action Says Two New Drug Pricing Studies Miss the Mark
This just in from Breast Cancer Action, a member of Prescription Access Litigation's coalition of 130+ consumer advocacy organizations. The pricing of cancer drugs is one of the most troubling trends in the world of prescription drugs. This press releas
Judge Allows Zyprexa Class Action to Go Forward, Says Courts are “in the Strongest Position” to Protect Public from Fraudulent Drug Marketing
Federal Judge Allows Zyprexa Class Action to Go Forward
Says Courts are “in the Strongest Position” to Protect Public from Fraudulent Drug Marketing
BROOKLYN, NY – A U.S. District Court judge today issued a decision allowing to go forward a class action l
Deadline Approaching for Paxil Pediatric Settlement
Back in February, PAL and Public Citizen filed an objection to a $63.8 Million class action settlement in Illinois state court in a case alleging that GlaxoSmithKline, the maker of Paxil, knew the drug was dangerous and ineffective when taken by children
Federal Court Rules Against Three Drug Companies in Average Wholesale Price Case
A major victory occurred today in the massive Average Wholesale Price lawsuit in the U.S. District Court for the District of Massachusetts. PAL's press release on this is below. To learn more about this case, go here.
FOR IMMEDIATE RELEASE
June 21, 2007
House Subcommittee caves in to Big Pharma on FDA Preemption provision
FDANews Drug Daily Bulletin reported today:
The House Subcommittee on Health passed legislation renewing the Prescription Drug User Fee Act (PDUFA) and other provisions with few amendments after staff meetings resolved concerns including language elimina